Xencor (XNCR) Amortization of Deferred Charges (2023 - 2026)

Xencor (XNCR) reported Amortization of Deferred Charges of $4.7 million for Q1 2026, down 45.75% year-over-year from $8.7 million in Q1 2025, and down 36.07% quarter-over-quarter from $7.4 million in Q4 2025.

Xencor (XNCR) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends

Xencor (XNCR) has 4 years of Amortization of Deferred Charges data on file, last reported at $4.7 million in Q1 2026.

  • Amortization of Deferred Charges for Q1 2026 came in at $4.7 million, down 45.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.0 million (down 21.45% YoY), and the FY2025 annual result was $31.9 million, down 12.77% from the prior year.
  • Amortization of Deferred Charges eased to $4.7 million in Q1 2026 per XNCR's latest filing, from $7.4 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $9.7 million in Q1 2024 and troughed at $4.7 million in Q1 2026.
  • A 4-year average of $7.9 million and a median of $8.4 million in 2024 frame the typical range for Amortization of Deferred Charges.
  • The sharpest annual moves came in 2024 and 2026: Amortization of Deferred Charges soared 40.47% in 2024, then slumped 45.75% in 2026.
  • A 4-year view of Amortization of Deferred Charges shows it stood at $6.2 million in 2023, then surged by 40.47% to $8.6 million in 2024, then retreated by 14.94% to $7.4 million in 2025, then plunged by 36.07% to $4.7 million in 2026.
  • Business Quant data shows XNCR's Amortization of Deferred Charges at $4.7 million in Q1 2026, $7.4 million in Q4 2025, and $7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Xencor 953.38 Mn 878.64 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4.70 Mn
Mar 31, 2026 4.70 Mn
Dec 31, 2025 7.35 Mn
Dec 31, 2025 7.35 Mn
Sep 30, 2025 7.66 Mn
Sep 30, 2025 7.66 Mn
Jun 30, 2025 8.24 Mn
Jun 30, 2025 8.24 Mn
Mar 31, 2025 8.66 Mn
Mar 31, 2025 8.66 Mn
Dec 31, 2024 8.64 Mn
Dec 31, 2024 8.64 Mn
Sep 30, 2024 9.01 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 9.27 Mn
Jun 30, 2024 9.27 Mn
Mar 31, 2024 9.67 Mn
Mar 31, 2024 9.67 Mn
Dec 31, 2023 6.15 Mn
Dec 31, 2023 6.15 Mn